Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-003807

EVP, Chief Operating Officer sold 827 shares at $18.09 ($14,960)

  • EVP, Chief Operating Officer gave up 423 shares (to pay taxes)
  • EVP, Chief Operating Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Szekeres David Leslie EVP, Chief Operating Officer 2021-01-13 Option exercise +1,250 1,250 D
Szekeres David Leslie EVP, Chief Operating Officer 2021-01-13 Shares withheld for taxes −423 $18.16 $7,682 827 D
Szekeres David Leslie EVP, Chief Operating Officer 2021-01-14 Sale −827 $18.09 $14,960 0 D
Derivatives
Szekeres David Leslie EVP, Chief Operating Officer 2021-01-13 Option exercise · Restricted Stock Units −1,250 18,750 D
Open-market sales · 827 sh · avg $18.09 · $14,960
Loading xslF345X03/doc4.xml…